Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rego Park, NY
NPI
1619082625
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
9725 63rd Dr
Rego Park, NY, 11374
Phone (718) 275-2900
Groups this clinician bills Medicare through
Medicare paid, 2024
$712K
25,894 services
Medicare patients, 2024
1,075
Average age 74
Drug cost, 2024
$23.3M
68,635 prescriptions
Company payments, 2025
$22K
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stella Ilyayeva was code 82962 (clinical chemistry), 1,633 times for 696 patients. In total Stella Ilyayeva billed 25,894 services in 109 codes, and Medicare paid $712K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82962 Clinical Chemistry | Office | 1,633 | 696 | $3.21 | $5,242 |
| 36415 Venipuncture Blood Collection | Office | 1,554 | 766 | $8.65 | $13K |
| 99214 Office E&M - Established | Office | 1,547 | 801 | $101.38 | $157K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,529 | 274 | $51.84 | $79K |
| 85025 Blood Count | Office | 1,359 | 683 | $7.61 | $10K |
| 83036 Blood Count | Office | 1,354 | 683 | $9.52 | $13K |
| 80053 Clinical Chemistry | Office | 1,353 | 682 | $10.35 | $14K |
| 84443 Clinical Chemistry | Office | 1,313 | 674 | $16.46 | $22K |
| 84439 Clinical Chemistry | Office | 1,302 | 674 | $8.84 | $12K |
| 80061 Clinical Chemistry | Office | 1,140 | 583 | $13.12 | $15K |
| 82306 Clinical Chemistry | Office | 1,094 | 645 | $28.99 | $32K |
| 82607 Clinical Chemistry | Office | 1,074 | 640 | $14.78 | $16K |
| 99213 Office E&M - Established | Office | 971 | 551 | $72.67 | $71K |
| 82043 Clinical Chemistry | Office | 873 | 475 | $5.66 | $4,941 |
| 83721 Clinical Chemistry | Office | 817 | 515 | $10.29 | $8,407 |
By year: 2022 $551K for 17,355 services; 2023 $704K for 30,886 services; 2024 $712K for 25,894 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 1,633 | 696 | $3.21 | $5,242 |
| 36415 Venipuncture Blood Collection | 1,554 | 766 | $8.65 | $13K |
| 85025 Blood Count | 1,359 | 683 | $7.61 | $10K |
| 83036 Blood Count | 1,354 | 683 | $9.52 | $13K |
| 80053 Clinical Chemistry | 1,353 | 682 | $10.35 | $14K |
| 84443 Clinical Chemistry | 1,313 | 674 | $16.46 | $22K |
| 84439 Clinical Chemistry | 1,302 | 674 | $8.84 | $12K |
| 80061 Clinical Chemistry | 1,140 | 583 | $13.12 | $15K |
| 82306 Clinical Chemistry | 1,094 | 645 | $28.99 | $32K |
| 82607 Clinical Chemistry | 1,074 | 640 | $14.78 | $16K |
Medicare prescription drug claims, 2024
In 2024, the drug Stella Ilyayeva prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 5,520 prescriptions and refills. In total Stella Ilyayeva wrote 68,635 Medicare prescriptions that cost $23.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 5,520 | 7,458 | 1,051 | $4.2M |
| Metformin Hcl Generic | 3,539 | 5,417 | 766 | $88K |
| Ozempic Semaglutide | 3,061 | 3,834 | 582 | $3.2M |
| Pioglitazone Hcl Generic | 2,974 | 4,628 | 610 | $20K |
| Glimepiride Generic | 2,372 | 3,563 | 500 | $16K |
| Glipizide Generic | 2,209 | 3,249 | 429 | $16K |
| Levothyroxine Sodium Generic | 2,197 | 3,559 | 404 | $14K |
| Synthroid Levothyroxine Sodium | 2,159 | 3,238 | 323 | $104K |
| Janumet Sitagliptin Phos/Metformin Hcl | 1,853 | 2,494 | 302 | $1.3M |
| Trulicity Dulaglutide | 1,736 | 2,152 | 340 | $2.0M |
| Mounjaro Tirzepatide | 1,720 | 1,993 | 316 | $2.0M |
| Atorvastatin Calcium Generic | 1,682 | 2,596 | 414 | $9,353 |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 1,494 | 2,260 | 473 | $24K |
| Rosuvastatin Calcium Generic | 1,358 | 1,988 | 301 | $8,567 |
| Metoprolol Succinate Generic | 1,230 | 1,886 | 301 | $11K |
Brand drugs: 29,342 claims; generic drugs: 33,040 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stella Ilyayeva $22K ($22K in general payments such as food, travel and fees) from 30 companies. The largest payer was Amgen Inc. with $13K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 42 | $13K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $3,903 |
| Lilly USA, LLC LLY | 8 | $1,052 |
| Corcept Therapeutics CORT | 18 | $656 |
| Amphastar Pharmaceuticals, Inc. AMPH | 41 | $637 |
| Mannkind Corporation MNKD | 22 | $601 |
| Novo Nordisk Inc NVO | 10 | $348 |
| Abbott Laboratories ABT | 14 | $339 |
| Intra-Sana Laboratories | 12 | $328 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $243 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.